Equities

Uni-Bio Science Group Ltd

Uni-Bio Science Group Ltd

Actions
  • Price (HKD)0.077
  • Today's Change0.00 / 0.00%
  • Shares traded4.83m
  • 1 Year change+42.59%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in HKDIncome statement in HKDView more

Year on year Uni-Bio Science Group Ltd grew revenues 10.08% from 440.32m to 484.72m while net income improved 84.04% from 38.51m to 70.88m.
Gross margin83.51%
Net profit margin19.44%
Operating margin20.59%
Return on assets24.76%
Return on equity36.79%
Return on investment32.97%
More ▼

Cash flow in HKDView more

In 2023, Uni-Bio Science Group Ltd increased its cash reserves by 31.58%, or 31.02m. The company earned 98.85m from its operations for a Cash Flow Margin of 20.39%. In addition the company generated 24.51m cash from financing while 76.14m was spent on investing.
Cash flow per share0.019
Price/Cash flow per share3.99
Book value per share0.0514
Tangible book value per share0.045
More ▼

Balance sheet in HKDView more

Uni-Bio Science Group Ltd has a Debt to Total Capital ratio of 22.67%, a higher figure than the previous year's 2.72%.
Current ratio2.50
Quick ratio2.17
Total debt/total equity0.2932
Total debt/total capital0.2267
More ▼

Growth rates in HKD

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
59.76
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.